Market overview
The global gastrointestinal surgery nutrition market is worth USD 763 mn in 2026 and is forecast to reach USD 1.4 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Immunonutrition drinks is the largest by product segment.
| Scope | Oral and tube-fed nutrition used before and after stomach, bowel and other digestive surgery: immunonutrition drinks, pre-operative carbohydrate drinks, recovery supplements and enteral formulas. |
|---|---|
| Industry | Food and Beverage |
| Value 2025 | USD 720 mn |
| Value 2026 | USD 763 mn |
| Value 2036 | USD 1.4 bn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 94.5 million units |
| Volume 2036 | 153 million units |
| Average price 2026 | USD 8.08 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Gastrointestinal Surgery Nutrition market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 763.2 mn |
| 2027 | USD 809.0 mn |
| 2028 | USD 857.5 mn |
| 2029 | USD 909.0 mn |
| 2030 | USD 963.5 mn |
| 2031 | USD 1.02 bn |
| 2032 | USD 1.08 bn |
| 2033 | USD 1.15 bn |
| 2034 | USD 1.22 bn |
| 2035 | USD 1.29 bn |
| 2036 | USD 1.37 bn |
Gastrointestinal Surgery Nutrition market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Immunonutrition drinks | 34.0% | 34.3% | USD 259 mn | 6.1% |
| Pre-operative carbohydrate drinks | 18.0% | 19.9% | USD 137 mn | 7.1% |
| Post-operative oral supplements | 28.0% | 25.7% | USD 214 mn | 5.1% |
| Enteral tube feeds | 20.0% | 20.2% | USD 153 mn | 6.1% |
By setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 66.0% | 63.5% | USD 504 mn | 5.6% |
| Outpatient and home recovery | 22.0% | 25.5% | USD 168 mn | 7.6% |
| Long-term care | 12.0% | 11.0% | USD 92 mn | 5.1% |
By surgery type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Colorectal | 34.0% | 33.0% | USD 259 mn | 5.7% |
| Gastric and upper GI | 28.0% | 28.0% | USD 214 mn | 6.0% |
| Pancreatic and liver | 20.0% | 20.0% | USD 153 mn | 6.0% |
| Bariatric | 18.0% | 19.0% | USD 137 mn | 6.6% |
By patient group
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adults below 65 | 48.0% | 44.0% | USD 366 mn | 5.1% |
| Older adults | 44.0% | 48.0% | USD 336 mn | 6.9% |
| Paediatric | 8.0% | 8.0% | USD 61 mn | 6.0% |
By funding source
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Public health systems | 58.0% | 55.0% | USD 443 mn | 5.4% |
| Private insurance | 26.0% | 27.0% | USD 198 mn | 6.4% |
| Out of pocket | 16.0% | 18.0% | USD 122 mn | 7.3% |
Top 25 countries for gastrointestinal surgery nutrition by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.5% of 2026 revenue and the 25 countries below together hold 95.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 206 mn | 27.0% | USD 364 mn | 5.8% |
| 2 | Germany | USD 76 mn | 10.0% | USD 123 mn | 4.9% |
| 3 | Japan | USD 69 mn | 9.0% | USD 111 mn | 4.9% |
| 4 | China | USD 61 mn | 8.0% | USD 149 mn | 9.3% |
| 5 | France | USD 53 mn | 7.0% | USD 90 mn | 5.4% |
| 6 | United Kingdom | USD 46 mn | 6.0% | USD 77 mn | 5.3% |
| 7 | Italy | USD 38 mn | 5.0% | USD 64 mn | 5.3% |
| 8 | Spain | USD 31 mn | 4.0% | USD 53 mn | 5.7% |
| 9 | Netherlands | USD 27 mn | 3.5% | USD 45 mn | 5.4% |
| 10 | Australia | USD 23 mn | 3.0% | USD 42 mn | 6.3% |
| 11 | South Korea | USD 15 mn | 2.0% | USD 31 mn | 7.3% |
| 12 | Canada | USD 11 mn | 1.4% | USD 17 mn | 4.8% |
| 13 | Brazil | USD 8.9 mn | 1.2% | USD 18 mn | 7.3% |
| 14 | India | USD 7.7 mn | 1.0% | USD 20 mn | 9.8% |
| 15 | Poland | USD 6.9 mn | 0.9% | USD 14 mn | 7.4% |
| 16 | Sweden | USD 6.3 mn | 0.8% | USD 10.0 mn | 4.8% |
| 17 | Belgium | USD 5.8 mn | 0.8% | USD 9.3 mn | 4.8% |
| 18 | Switzerland | USD 5.4 mn | 0.7% | USD 8.6 mn | 4.7% |
| 19 | Austria | USD 5.1 mn | 0.7% | USD 8.2 mn | 4.8% |
| 20 | Turkey | USD 4.9 mn | 0.6% | USD 9.8 mn | 7.3% |
| 21 | Russia | USD 4.7 mn | 0.6% | USD 6.3 mn | 3.0% |
| 22 | Taiwan | USD 4.4 mn | 0.6% | USD 7.1 mn | 4.8% |
| 23 | Mexico | USD 4.3 mn | 0.6% | USD 8.8 mn | 7.4% |
| 24 | Saudi Arabia | USD 4.1 mn | 0.5% | USD 8.3 mn | 7.3% |
| 25 | Denmark | USD 4.0 mn | 0.5% | USD 6.3 mn | 4.7% |
| Rest of world | USD 35 mn | 4.6% | USD 66 mn | 6.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Nestlé Health Science
- Abbott
- Nutricia
- Fresenius Kabi
Group 2: Regional and specialist players
- Meiji Holdings
- Terumo
- B. Braun
- Ajinomoto
- Otsuka Pharmaceutical Factory
- Morinaga Milk
Group 3: Emerging and niche players
- Kate Farms
- Real Food Blends
- Vegenat
- Nualtra
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the gastrointestinal surgery nutrition market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by product, by setting, by surgery type, by patient group, by funding source. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the gastrointestinal surgery nutrition market?
The global gastrointestinal surgery nutrition market is estimated at USD 720 mn in 2025 and USD 763 mn in 2026.
How fast will the gastrointestinal surgery nutrition market grow?
It is forecast to reach USD 1.4 bn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 604 mn.
Which country is the largest market for gastrointestinal surgery nutrition?
United States is the largest market by revenue at USD 206 mn in 2026, 27.0% of the global total. The three largest countries together hold 46.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.3% a year from 2026 to 2036.
Which gastrointestinal surgery nutrition segment is largest?
In the by product split, Immunonutrition drinks is the largest segment with 34.0% of 2026 revenue.
Who are the leading gastrointestinal surgery nutrition companies?
Global leaders include Nestlé Health Science, Abbott, Nutricia, Fresenius Kabi.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Food and Beverage
- BiscottiUSD 773 mn · 4.6% CAGR
- Fish Protein HydrolysateUSD 752 mn · 7.5% CAGR
- Ascorbic AcidUSD 752 mn · 4.5% CAGR
- Pea ProteinUSD 777 mn · 10.0% CAGR
- Marine Protein HydrolysateUSD 746 mn · 6.5% CAGR
- Insect ProteinUSD 788 mn · 22.0% CAGR
- Citrus Fiber PectinUSD 738 mn · 7.2% CAGR
- Rumen Energy OptimizersUSD 798 mn · 5.2% CAGR